Pick any GP practice or PCN to see how its monthly prescribing stacks up against its PCN, Sub-ICB and the whole of England — net cost per weighted patient, generic prescribing, low-priority "items of limited value" and antibiotic stewardship, drawn from the NHSBSA English Prescribing Dataset (EPD), with an estimated QIPP saving against peer medians.
Contains public sector information licensed under the Open Government Licence v3.0. Source: NHS Business Services Authority (NHSBSA), English Prescribing Dataset. Generic, low-priority and stewardship measures are computed by Haresign using standard BNF code-list methodology and are indicative.
Month
The national prescribing picture across England — every GP practice combined, from the NHSBSA EPD. No practice selection needed.
Net cost per weighted patient — England
Average drug spend per weighted patient each month across all practices.
Generic prescribing rate — England
Generic items as a share of all drug items.
Cost distribution across practices
Spread of net cost per weighted patient — min, quartiles, max.
Search for a practice or PCN to load its prescribing dashboard.
—
—
—
What's changed
Auto-generated from the months of data loaded — the direction of travel against England.
Prescribing scorecard
This practice against its PCN, Sub-ICB and England across every measure.
Estimated QIPP headroom
If this practice prescribed at the peer median net cost per weighted patient.
Top-down headroom vs peer median
If this practice prescribed at the peer median net cost per weighted patient. Annualised; indicative — confirm against ePACT2 before acting.
Itemised switch opportunities
Bottom-up — specific, actionable levers behind the headline, each with an estimated annual value.
Spend by therapeutic area (BNF chapter)
Where this practice's drug spend goes, with the England share alongside each area to spotlight over-/under-weight categories.
Population-level prescribing volume by therapeutic area (per 1,000 patients / dose-standardised ADQ / STAR-PU), benchmarked against England. These are targeting signals, not patient-level audit — EPD is aggregate volume, not indication-linked.
Why is spend high or low?
Splits cost into volume (items per weighted patient) and price (cost per item), each against England — they need different interventions.
Practices like you
Benchmarked against demographically-similar peers (list size ±30% and a comparable 65+ share) — fairer than raw national ranking.
Biggest risers
Largest spend increases by therapeutic area.
Biggest fallers
Largest spend decreases by therapeutic area.
Spend forecast
Linear projection of total monthly spend from the months loaded — indicative direction of travel.
Net cost per weighted patient over time
Generic prescribing rate over time
Low-priority spend share over time
Lowest net cost per weighted patient
National leaders, plus practices either side of you.
Highest generic prescribing rate
National leaders, plus practices either side of you.
PCN Leaderboard
Member practices ranked by net cost per weighted patient (lowest first).
Head-to-head comparison
Type to add up to six practices or PCNs and benchmark them side by side for the selected month.
Search
Unlock your Practice Performance Overview
Register your practice for free to bring QOF, workforce, access, finance, contract and CQC data into a single live dashboard — benchmarked to national figures with an at-a-glance health score.
This site uses cookies — essential cookies for security and analytics cookies (Google Analytics) to understand how visitors use the site.
Privacy Policy
